Table. Prevalence of SAV viremia in the study population, Republic of Korea, January 2002–June 2006*.
| Group | Sex (M/F) | Age range (mean age) | No. tested | No. positive (%) | p value |
|---|---|---|---|---|---|
| Control | 48/33 | 1 mo–15 y (47 mo) | 81 | 28 (34.5) | |
| Hepatitis | 44/37 | 1 mo–15 y (58 mo) | 81 | 29 (35.8) | 1 |
| HBV | 8/12 | 1–15 y | 20 | 10 (50) | 0.30 |
| HCV | 11/0 | 3–10 y | 11 | 5 (45.4) | 0.71 |
| Others | 10/9 | 0–13 y | 19 | 7 (36.8) | 0.93 |
| Unknown | 15/16 | 0–13 y | 31 | 7 (22.5) | 0.3 |
| ARD | 22/18 | 0–5 y (18 mo) | 40 | 27 (67.5) | 0.001† |
| Vasculitis | 22/8 | 1–10 y (46 mo) | 30 | 10 (33.3) | 0.91 |
| KD | 9/3 | 1–9 y | 12 | 6 (50) | 0.47 |
| HSP | 13/5 | 2–10 y | 18 | 4 (22.2) | 0.46 |
| Total | 136/96 | 1 mo–15 y | 232 | 94 (40.5) |
*SAV, small anellovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; ARD, acute respiratory tract disease; KD, Kawasaki disease; HSP, Henoch-Schonlein purpura. †p<0.05, statistically significant.